Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

Abstract

Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults (Review)

Attention deficit/hyperactivity disorder (ADHD) in children: more focus on care and support, less on diagnosis

“…Teachers rated methylphenidate and modafinil as beneficial 16. But Cochrane reviews have questioned the quality of this evidence,1718192021 and other reviews have emphasised the scarcity of long term data 1622. The lack of high quality, long term evidence is apparent in clinical guidance—for example, the 2022 Australian Clinical Practice Guidelines for ADHD say that first line drug treatment is supported by only low quality evidence 23.…”